Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
15 studies found for:    "Spastic paraparesis"
Show Display Options
Rank Status Study
1 Completed MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
Condition: Tropical Spastic Paraparesis
Intervention:
2 Unknown  Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases
Conditions: HTLV-1;   Tropical Spastic Paraparesis;   Immune System Diseases;   Physical Disability;   Pentoxifylline
Interventions: Drug: Pentoxifylline;   Drug: Placebo
3 Enrolling by invitation Urological Physical Therapy in HTLV-1 With Urinary Symptoms
Conditions: Tropical Spastic Paraparesis;   HTLV-1
Intervention: Procedure: Urological physical therapy
4 Recruiting Evaluation of Patients With HAM/TSP
Conditions: HTLV-I Infection;   Tropical Spastic Paraparesis
Intervention:
5 Suspended Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Condition: HTLV-1
Intervention: Drug: Hu MiK-Beta-1
6 Unknown  Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Tamibarotene
7 Completed Assessment of Patients With Multiple Sclerosis (MS)
Conditions: Herpesviridae Infection;   HTLV-I Infection;   Multiple Sclerosis;   Tropical Spastic Paraparesis;   Vasculitis
Intervention:
8 Completed Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)
Conditions: HTLV-I Infection;   Spinal Cord Disease;   Tropical Spastic Paraparesis
Intervention: Drug: Recombinant human interferon beta-1a
9 Active, not recruiting Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
Conditions: Amyotrophic Lateral Sclerosis;   Lou Gehrig's Disease;   Primary Lateral Sclerosis;   Nervous System Diseases;   Hereditary Spastic Paraparesis
Intervention: Other: No intervention
10 Completed A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis
Condition: HTLV-I
Intervention:
11 Completed Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Condition: HTLV I Associated Myelopathy
Intervention: Drug: ciclosporin
12 Unknown  Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)
Condition: Paraparesis Spastic Tropical
Interventions: Drug: Valproic acid;   Drug: costicosteroids;   Drug: valproid acid plus corticosteroids
13 Recruiting Raltegravir for HAM/TSP
Conditions: HAM/TSP;   HTLV-1
Intervention: Drug: Raltegravir
14 Completed Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
Conditions: Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Amyotrophic Lateral Sclerosis
Intervention:
15 Completed Physiologic Studies of Spasticity
Conditions: Muscle Spasticity;   Healthy
Intervention:

Indicates status has not been verified in more than two years